Inhibition of pericellular plasminogen activation by apolipoprotein(a): Roles of urokinase plasminogen activator receptor and integrins αMβ2 and αVβ3
Atherosclerosis May 24, 2018
Romagnuolo R, et al. - Researchers assessed the role of potential receptors in regulating plasminogen activation and the ability of apolipoprotein(a) (apo(a)) to mediate inhibition of plasminogen activation on vascular and monocytic/macrophage cells via knockdown (siRNA or blocking antibodies) or overexpression of various candidate receptors. In order to determine apo(a) and plasminogen receptor interactions, binding assays were conducted. In mediating plasminogen activation, a role of receptors urokinase-type plasminogen activator receptor (uPAR), αMβ2, and αVβ3 was highlighted. Via these receptors, apo(a) exerted inhibitory impacts on plasminogen activation. The necessity of identified domains in apo(a) for plasminogen activation inhibition was also reported. Findings also revealed uPAR bound to apo(a) in vitro.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries